TY - JOUR AU - Bouwman, Linda AU - Eeltink, Corien M. AU - Visser, Otto AU - Janssen, Jeroen J. W. M. AU - Maaskant, Jolanda M. PY - 2017 DA - 2017/11/09 TI - Prevalence and associated factors of medication non-adherence in hematological-oncological patients in their home situation JO - BMC Cancer SP - 739 VL - 17 IS - 1 AB - Medication non-adherence is associated with poor health outcomes and increased health care costs. Depending on definitions, reported non-adherence rates in cancer patients ranges between 16 and 100%, which illustrates a serious problem. In malignancy, non-adherence reduces chances of achievement of treatment response and may thereby lead to progression or even relapse. Except for Chronic Myeloid Leukemia (CML), the extent of non-adherence has not been investigated in hematological-oncological patients in an outpatient setting. In order to explore ways to optimize cancer treatment results, this study aimed to assess the prevalence of self-administered medication non-adherence and to identify potential associated factors in hematological-oncological patients in their home situation. SN - 1471-2407 UR - https://doi.org/10.1186/s12885-017-3735-1 DO - 10.1186/s12885-017-3735-1 ID - Bouwman2017 ER -